4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-096512
CEO & President sold 2,732 shares at $14.90 ($40,707)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Cox John · CEO & President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-05 | Sale : show line 1 in the form 10b5-1 | −2,732 | $14.90 | $40,707 | 374,145 | D |
| Open-market sales · 2,732 sh · avg $14.90 · $40,707 | ||||||
Loading xslF345X05/ownership.xml…